Expression of Histone Deacetylases in Diffuse Large B-cell Lymphoma and Its Clinical Significance

Background: Histone deacetylase inhibitors are a new class of drugs used in treatment of malignant tumors. Diffuse large B-cell lymphoma (DLBCL) is the most common type of B-cell lymphoma, and it accounts for more than 40% of all B-cell lymphomas. In this study, we aimed to determine the expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sung Hak, Yoo, Changyoung, Im, Soyoung, Jung, Ji-Han, Choi, Hyun Joo, Yoo, Jinyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115238/
https://www.ncbi.nlm.nih.gov/pubmed/25076845
http://dx.doi.org/10.7150/ijms.8522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115238/
https://www.ncbi.nlm.nih.gov/pubmed/25076845
http://dx.doi.org/10.7150/ijms.8522

Ejemplares similares